149 related articles for article (PubMed ID: 37811129)
1. Pharmacist Avoidance or Reductions in Medical Costs in Critically and Emergently Ill Pediatrics: PHARM-PEDS Study.
Kiskaddon AL; Smith MM; Gilliland F; Rech MA
Crit Care Explor; 2023 Oct; 5(10):e0980. PubMed ID: 37811129
[TBL] [Abstract][Full Text] [Related]
2. PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study.
Rech MA; Gurnani PK; Peppard WJ; Smetana KS; Van Berkel MA; Hammond DA; Flannery AH
Crit Care Explor; 2021 Dec; 3(12):e0594. PubMed ID: 34913039
[TBL] [Abstract][Full Text] [Related]
3. PHarmacist Avoidance or Reductions in Medical Costs in Patients Presenting the EMergency Department: PHARM-EM Study.
Rech MA; Adams W; Smetana KS; Gurnani PK; Van Berkel Patel MA; Peppard WJ; Hammond DA; Flannery AH
Crit Care Explor; 2021 Apr; 3(4):e0406. PubMed ID: 33912836
[TBL] [Abstract][Full Text] [Related]
4. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
Muñoz-Pichuante D; Villa-Zapata L
J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
[TBL] [Abstract][Full Text] [Related]
5. Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network.
Belcher RM; Blair A; Chauv S; Hoang Q; Hickman AW; Peng M; Baldwin M; Koch L; Nguyen M; Guidry D; Fontaine GV
Crit Care Explor; 2023 Jan; 5(1):e0839. PubMed ID: 36660010
[TBL] [Abstract][Full Text] [Related]
6. A cost avoidance study of critical care pharmacists' interventions in a tertiary institution in Singapore.
Chan LEJ; Soong JL; Lie SA
Am J Health Syst Pharm; 2023 Feb; 80(5):267-283. PubMed ID: 36371740
[TBL] [Abstract][Full Text] [Related]
7. Economic impact of pharmacist interventions in pediatric ambulatory care clinics.
Yung E; McNicol M; Lewis D; Fischer J; Petkus K; Sebastian S; Abdel-Rasoul M; Schmuhl K; Wise K
J Am Pharm Assoc (2003); 2021; 61(2):198-205.e1. PubMed ID: 33358098
[TBL] [Abstract][Full Text] [Related]
8. Cost-avoidance associated with implementation of an overnight emergency medicine pharmacist at a Level I Trauma, Comprehensive Stroke Center.
Nguyen MH; Gordon K; Reachi B; Bair J; Chauv S; Fontaine GV
Am J Emerg Med; 2024 May; 82():63-67. PubMed ID: 38805940
[TBL] [Abstract][Full Text] [Related]
9. Impact of Pharmacists to Improve Patient Care in the Critically Ill: A Large Multicenter Analysis Using Meaningful Metrics With the Medication Regimen Complexity-ICU (MRC-ICU) Score.
Sikora A; Ayyala D; Rech MA; Blackwell SB; Campbell J; Caylor MM; Condeni MS; DePriest A; Dzierba AL; Flannery AH; Hamilton LA; Heavner MS; Horng M; Lam J; Liang E; Montero J; Murphy D; Plewa-Rusiecki AM; Sacco AJ; Sacha GL; Shah P; Smith MP; Smith Z; Radosevich JJ; Vilella AL;
Crit Care Med; 2022 Sep; 50(9):1318-1328. PubMed ID: 35678204
[TBL] [Abstract][Full Text] [Related]
10. Impact of a pediatric clinical pharmacist in the pediatric intensive care unit.
Krupicka MI; Bratton SL; Sonnenthal K; Goldstein B
Crit Care Med; 2002 Apr; 30(4):919-21. PubMed ID: 11940770
[TBL] [Abstract][Full Text] [Related]
11. Evaluating reduction in medical costs associated with pharmacists' presence in the emergency department using a novel cost avoidance framework.
Poremba M; Champa K; Reichert E
Am J Health Syst Pharm; 2023 Aug; 80(Suppl 3):S111-S118. PubMed ID: 36525567
[TBL] [Abstract][Full Text] [Related]
12. Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients.
Leache L; Aquerreta I; Aldaz A; Monedero P; Idoate A; Ortega A
Res Social Adm Pharm; 2020 Sep; 16(9):1285-1289. PubMed ID: 31327737
[TBL] [Abstract][Full Text] [Related]
13. A qualitative dual-site analysis of the pharmacist discharge care (PHARM-DC) intervention using the CFIR framework.
Murry LT; Keller MS; Pevnick JM; Schnipper JL; Kennelty KA;
BMC Health Serv Res; 2022 Feb; 22(1):186. PubMed ID: 35151310
[TBL] [Abstract][Full Text] [Related]
14. Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.
Saokaew S; Maphanta S; Thangsomboon P
Pharm Pract (Granada); 2009 Apr; 7(2):81-7. PubMed ID: 25152782
[TBL] [Abstract][Full Text] [Related]
15. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
[TBL] [Abstract][Full Text] [Related]
16. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
Aghili M; Neelathahalli Kasturirangan M
JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
Perera PN; Guy MC; Sweaney AM; Boesen KP
J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
[TBL] [Abstract][Full Text] [Related]
18. Documentation of pharmacists' interventions in an emergency department and associated cost avoidance.
Lada P; Delgado G
Am J Health Syst Pharm; 2007 Jan; 64(1):63-8. PubMed ID: 17189582
[TBL] [Abstract][Full Text] [Related]
19. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
Altavela JL; Jones MK; Ritter M
J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and economic analysis of clinical pharmacist interventions during rounds in an acute care psychiatric hospital.
Gunterus A; Lopchuk S; Dunn C; Floyd R; Normandin B
Ment Health Clin; 2016 Sep; 6(5):242-247. PubMed ID: 29955477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
